Ata, Elenita .

HRN: 16-72-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2023
CEFTRIAXONE 1G (VIAL)
10/30/2023
11/06/2023
IV
2g
OD
Choledocholithiasis
Checking Final Appropriateness 
10/31/2023
CEFTRIAXONE 1G (VIAL)
10/31/2023
11/06/2023
IVTT
1gram
Q12
Uti
Checking Final Appropriateness 
11/05/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/05/2023
11/11/2023
IV
500mg
Q8
T/C Obstructive Jaundice Sec To Choledocholelithiases
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: